Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-70
SponsorMayo Clinic
About this trial
This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.
Eligibility criteria
Qualifiers
Undergoing gastric bypass surgery
Confirmed AUROC F=0 or F>2 liver fibrosis
Age 30-70 years
BMI greater than 40 kg/m2
Disqualifiers
Autoimmune diseases
Hepatitis B or C positive
Heavy alcohol use
Active smoking history
Trial design
Treatments tested in this trial
- Bariatric surgery
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
1Mayo Clinic in Arizona85259, ScottsdaleArizona, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov